Pharmaceutical News and Articles

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del Trikafta-Responsive Variants

How to Manage the Blues this Holiday Season

watch a favorite classic movie, make a family dish or continue a family tradition that they loved.6. Expand your idea of self-care. It s not just about bubble b

LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus

December 19, 2024 LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today

New Legislation Will Help Schools Handle Heart Emergencies

Schoolkids will be better able to save the life of a cardiac arrest victim, thanks to a new law signed this week by President Joe Biden.The Cardiomyopathy Healt

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Vertex Pharmaceuticals Incorporated (Nasdaq VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1

FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications

Data Suggests TNF Inhibitors Help Prevent Serious Complications in Children with Crohn's Disease

FRIDAY, Dec. 27, 2024 A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn s disease. A new study published

FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicr

Age Impacts Surgical Outcomes for Breast Reconstruction

For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively correlated with the Satisfaction with B

Global Prevalence of Autism Spectrum Disorder Is High

The global prevalence and rank of nonfatal burden of autism spectrum disorder are high, according to a review published online Dec. 19 in The Lancet Psychiatry.